"Practice makes perfect" seems logical, but how much practice remains uncertain, and current health care quality guidelines may be set too high. It may be time to reexamine the standard recommending hospitals perform at least 400 angioplasty and stent proc
The newly developed pulsed-dye laser surgery for voice disorders has been found to be faster, cheaper, better tolerated, and less complicated than standard surgery that requires general anesthesia, more time and a longer recovery, surgeons reported here to
People with cancer that has spread to the brain - about 40 percent of all cancer cases - live longer and enjoy a better quality of life if they are treated with a combination of radiation techniques, according to research conducted, in part, at the Jame
Surgery to cut part of the nerves to the heart can reduce the risk of fainting or sudden death in young people with a heart rhythm disorder called long QT syndrome (LQTS), researchers reported in today's rapid access issue of Circulation: Journal of
ABIOMED, Inc. today announced the 14th implantation of the AbioCor? Implantable Replacement Heart. The implant was performed on May 24 in Louisville, KY by a Jewish
NYU Medical Center has begun enrolling patients in the first large-scale clinical trial of chelation therapy, a controversial treatment for heart disease widely practiced by complementary and alternative medicine physicians. The new, governm
Umbilical cord blood and bone marrow transplants at Loyola University Health System, Maywood, Ill., are curing or slowing the progression of many cancers originating in the bone marrow (i.e., leukemia, my
A common surgical procedure to prevent the cervix opening during pregnancy-thought to reduce the risk of preterm delivery-is called into question by results of a study in this week's issue of THE LANCET.
A UK study in this week's issue of THE LANCET highlights how surgery in addition to compression treatment could substantially reduce the risk of recurrent leg ulcers.Venous leg ulceration affects 1
Knee replacement operations have more than doubled in a decade, with one in five ops second time around (revision) surgery, reveals research in the Annals of the Rheumatic Diseases.But the figures also show that those who are well off are more li
Date: Sunday, 28-Jan-2007
Uterine artery embolization, a less-invasive treatment for uterine fibroids, is as effective as hysterectomy and myomectomy, according to a study published in the Jan. 25 issue of the New England Journal of Medicine, the Washington Post reports (Washington Post, 1/25).Uterine artery embolization -- which involves a small abdominal incision and local anesthesia -- has a lower rate of complications and requires less recovery time than hysterectomy and is usually covered by health insurance (Kaiser Daily Women's Health Policy Report, 11/7/06). For the study, Richard Edwards of Gartnavel General Hospital in Glasgow, Scotland, and colleagues randomly assigned 106 women with uterine fibroids to receive uterine artery embolization and 51 to receive surgery -- most of which were hysterectomies while some were myomectomies, a procedure that removes fibroids while leaving the uterus intact. After the procedures, the participants -- admitted in 27 hospitals across the United Kingdom -- rated pain levels, mental health, the recovery process and other factors. The study found that the uterine artery embolization group recovered faster, with a median hospital stay one day, compared with five days for the participants in the surgery group. About 13% of women in the uterine artery embolization group were readmitted to the hospital after one year, including 10% who needed to repeat the procedure or needed a hysterectomy because of recurrent symptoms, the study found (Chang, AP/South Florida Sun-Sentinel, 1/24). One year after the treatment, 93% of the participants who underwent surgery said they would recommend that option, while 88% who received uterine artery embolization said they would recommend the procedure, according to the study (Emery, Reuters, 1/24). According to the Post, surgery cost about $2,500 more than uterine artery embolization (Washington Post, 1/25).
"The results of our study make clear that the choice between surgery and [uterine artery embolization] for symptomatic uterine fibroids involves trade-offs," the researchers wrote, adding that longer follow-up is necessary to asses the need for repeated uterine artery embolization procedures and "to inform future decision making." In a related NEJM editorial, Togas Tulandi of McGill University said that a key factor in choosing uterine artery embolization is whether the woman wants to become pregnant. The effect of the treatment on pregnancy is unclear, so surgery "should be the first line of treatment for women with symptomatic uterine fibroids who wish to conceive," Tulandi writes, adding that for women with diffuse fibroids, uterine artery embolization should be considered (Reuters Health, 1/24).
The study is available online.
This article is republished with kind permission from our friends at the The Kaiser Family Foundation. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery of in-depth coverage of health policy developments, debates and discussions. The Kaiser Daily Health Policy Report is published for Kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation. Copyright 2007 Advisory Board Company and Kaiser Family Foundation. All rights reserved.